US 12,241,099 B2
Peptide therapeutics for treating Alzheimer's disease and related conditions
Anne Kasus-Jacobi, Midwest City, OK (US); Heloise Anne Pereira, Edmond, OK (US); and Amanda J. Stock, Nottingham, MD (US)
Assigned to The Board of Regents of the University of Oklahoma, Norman, OK (US)
Filed by The Board of Regents of the University of Oklahoma, Norman, OK (US)
Filed on Dec. 8, 2020, as Appl. No. 17/115,321.
Application 17/115,321 is a continuation in part of application No. PCT/US2019/036281, filed on Jun. 10, 2019.
Claims priority of provisional application 62/682,455, filed on Jun. 8, 2018.
Prior Publication US 2021/0115426 A1, Apr. 22, 2021
Int. Cl. C07K 14/00 (2006.01); A61K 38/00 (2006.01); A61K 38/48 (2006.01); A61P 25/28 (2006.01); C07K 14/47 (2006.01); C12N 9/64 (2006.01); C12N 9/96 (2006.01)
CPC C12N 9/6424 (2013.01) [A61K 38/482 (2013.01); A61K 38/486 (2013.01); A61P 25/28 (2018.01); C07K 14/4723 (2013.01); C12N 9/6448 (2013.01); C12N 9/96 (2013.01); C12Y 304/2102 (2013.01); C12Y 304/21037 (2013.01); A61K 38/00 (2013.01)] 18 Claims
 
1. A peptide compound comprising a peptide comprising amino acid sequence SEQ ID NO: 20.